Livzon Pharmaceutical | Sustainability Performance
Engages in the development, production, and sale of pharmaceuticals and healthcare products. Portfolio includes prescription drugs, active pharmaceutical ingredients, and medical supplies across therapeutic areas. Activities also extend to research and clinical development, supported by domestic and international partnerships.
1985
China
5,001 - 10,000 employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#10719
Overallⓘ#730
in Chinaⓘ#258
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
- Livzon Pharmaceutical Group Inc, Chinese pharmaceutical major, has faced sustained Chinese NMPA enforcement scrutiny over alleged inadequate disclosure of multiple Chinese pharmaceutical product quality at multiple production facilities, plus the contested historic 2024 Chinese government NRDL price negotiations affecting Livzon's premium pricing and institutional shareholders amid Chinese pharma market normalization.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
2-3
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.